Skip to main content
. 2024 May 16;7:577. doi: 10.1038/s42003-024-06283-6

Table 2.

Clinical characteristics of PXE patients

Phenodex-FlorMore
Patient Skin Eye Gastro intestinal Vascular Cardiac Renal
#1 3 4 0 0 0 0 graphic file with name 42003_2024_6283_Taba_HTML.gif
#2 2 4 0 2 1 0
#3 3 6 0 0 0 0

Axillary and arm areas show typical skin papules and laxity (CAS=clinically affected skin) and absence of skin alterations (CUS clinically unaffected skin), respectively. The Phenodex-FlorMore scoring system for the evaluation of PXE clinical manifestations. Image is published with the informed consent of the patient.